Gf Fund Management Co. Ltd. Gilead Sciences, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 292,840 shares of GILD stock, worth $31.2 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
292,840
Previous 284,356
2.98%
Holding current value
$31.2 Million
Previous $26.3 Billion
24.92%
% of portfolio
0.77%
Previous 0.57%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,156Shares Held
987MCall Options Held
8.73MPut Options Held
9.44M-
Black Rock Inc. New York, NY121MShares$12.9 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.3 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.64 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.43 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.17 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $134B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...